IS8103A - Lyfjablanda sem felur í sér ónæmisbreyti makrólíðs - Google Patents

Lyfjablanda sem felur í sér ónæmisbreyti makrólíðs

Info

Publication number
IS8103A
IS8103A IS8103A IS8103A IS8103A IS 8103 A IS8103 A IS 8103A IS 8103 A IS8103 A IS 8103A IS 8103 A IS8103 A IS 8103A IS 8103 A IS8103 A IS 8103A
Authority
IS
Iceland
Prior art keywords
immune response
pharmaceutical preparation
preparation containing
containing macrolide
macrolide
Prior art date
Application number
IS8103A
Other languages
English (en)
Icelandic (is)
Inventor
Grassberger Maximilian
Hirsch Stefan
Karl Mayer Friedrich
Sekkat Nabila
Stütz Anton
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IS8103A publication Critical patent/IS8103A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS8103A 2003-04-04 2005-10-31 Lyfjablanda sem felur í sér ónæmisbreyti makrólíðs IS8103A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307867.2A GB0307867D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition
PCT/EP2004/003514 WO2004087202A2 (en) 2003-04-04 2004-04-02 Pharmaceutical composition comprising a macrolide immunomodulator

Publications (1)

Publication Number Publication Date
IS8103A true IS8103A (is) 2005-10-31

Family

ID=9956230

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8103A IS8103A (is) 2003-04-04 2005-10-31 Lyfjablanda sem felur í sér ónæmisbreyti makrólíðs

Country Status (12)

Country Link
US (2) US20070021377A1 (enExample)
EP (1) EP1638558A2 (enExample)
JP (1) JP2006522060A (enExample)
CN (1) CN1764455A (enExample)
BR (1) BRPI0409169A (enExample)
CA (1) CA2519958A1 (enExample)
GB (1) GB0307867D0 (enExample)
IS (1) IS8103A (enExample)
MX (1) MXPA05010704A (enExample)
NO (1) NO20055170L (enExample)
RS (1) RS20050723A (enExample)
WO (1) WO2004087202A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2885491B1 (fr) * 2005-05-16 2020-03-06 Nutricos Technologies Traitement de la secheresse keratinique par des glycerides
DE102007052380A1 (de) * 2007-10-31 2009-05-07 Bitop Ag Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten
CN120754078A (zh) * 2024-07-30 2025-10-10 中山大学 亚油酸在制备提高革兰氏阳性菌对抗生素敏感性药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9221220D0 (en) * 1992-10-09 1992-11-25 Sandoz Ag Organic componds
FR2710527B1 (fr) * 1993-09-30 1995-12-08 Roussel Uclaf Nouvelles compositions cosmétiques et dermatologiques associant céramides et acide linoléique, leur préparation.
JPH08133979A (ja) * 1994-09-16 1996-05-28 Sando Yakuhin Kk 局所適用薬剤組成物
EP0786986B1 (en) * 1994-10-26 2002-03-20 Novartis AG Use of an unsaturated fatty alcohol
DE19544507B4 (de) * 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
AU749623B2 (en) * 1998-03-26 2002-06-27 Astellas Pharma Inc. Sustained release preparations
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
GB0125443D0 (en) * 2001-10-23 2001-12-12 Novartis Ag Organic Compounds
GB0200429D0 (en) * 2002-01-09 2002-02-27 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
CN1764455A (zh) 2006-04-26
CA2519958A1 (en) 2004-10-14
EP1638558A2 (en) 2006-03-29
JP2006522060A (ja) 2006-09-28
US20080132534A1 (en) 2008-06-05
NO20055170D0 (no) 2005-11-03
GB0307867D0 (en) 2003-05-14
MXPA05010704A (es) 2005-12-12
BRPI0409169A (pt) 2006-04-11
WO2004087202A3 (en) 2005-02-03
US20070021377A1 (en) 2007-01-25
NO20055170L (no) 2006-01-04
AU2004226822A1 (en) 2004-10-14
RS20050723A (sr) 2007-11-15
WO2004087202A2 (en) 2004-10-14

Similar Documents

Publication Publication Date Title
IS2946B (is) Lyfjablanda sem felur í sér andrógen
DK1615646T4 (da) Farmaceutiske formuleringer, der indeholder methylnaltrexon
DE602004017700D1 (de) Transmukosen verabreichung
ATE407663T1 (de) Azithromycin enthaltende pharmazeutische zusammensetzungen mit verringerten nebenwirkungen
GB0320382D0 (en) Pharmaceutical compositions
GB0327723D0 (en) Pharmaceutical compositions
ATE363895T1 (de) Zubereitungen enthaltend sucralose
RS20120139A3 (en) 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments
IS8351A (is) Lyfjaafurðir sem fela í sér bisfosfónöt
DK1587478T3 (da) Farmaceutisk sammensætning
IL173195A0 (en) Cyclovinylazoline derivatives, their preparation and pharmaceutical compositions containing them
GB0300531D0 (en) Pharmaceutical compositions
EP1648411A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0316206D0 (en) Pharmaceutical formulation
ZA200605080B (en) Pharmaceutical compositions
DK1680088T3 (da) Smagsmaskeret formulering indeholdende clarithromycin
ATE546141T1 (de) Pharmazeutisches injektionspräparat
PT1603550E (pt) Composição farmacêutica que compreende ácido 5-metil-2-2¿- (cloro-6¿-fluoroanilino)fenilacético
IS8103A (is) Lyfjablanda sem felur í sér ónæmisbreyti makrólíðs
IS8366A (is) Lyfjablanda sem felur í sér pýrimídín-A-ónafleiðuhjúpaða með sýrufjölliðu
EP1669087A4 (en) PREPARATION CONTAINING A BASIC MEDICINAL PRODUCT
IL172758A0 (en) Pharmaceutical compositions containing balaglitazone and methods for the preparation thereof
NO20042074L (no) Makrolider inneholdende farmasoytiske sammensetninger
GB0305579D0 (en) Pharmaceutical compositions
IL175246A0 (en) Solid pharmaceutical preparation form